Equity in newborn sequencing: a capability approach perspective

Abstract Definition of the problem Newborn sequencing (NBSeq) offers the potential to detect hundreds of genetic conditions from infancy. On this basis, some consider NBSeq to be a revolutionizing equalizer, promising access to genomic testing for all newborns. However, the unique nature of equity in NBSeq has been oversimplified in the literature; the existing debate mainly highlights universal access as an automatic means of ensuring fair health outcomes. Arguments We apply the Capability Approach (CA) to argue that providing access alone is not sufficient to achieve equity. Instead, the emphasis should be placed on developing capabilities that enable people to use NBSeq effectively and achieve meaningful health outcomes. Using capabilities as a measure of justice and eventually developing our own list, we provide an overview of systemic barriers within the process, including the underrepresentation of genomic data and variations in health literacy. This model allows us to extrapolate how these factors can affect individuals—particularly those from underserved backgrounds—in their ability to translate the benefits and outcomes provided by NBSeq into improved well-being throughout their lifespan. Conclusion The CA provides a pluralistic perspective on equity in NBSeq by emphasizing an important distinction for justice in healthcare: the distinction between simply doing NBSeq and having the real freedom to choose to do NBSeq and then doing it. Equity in NBSeq requires refining justice by not only increasing access to the service itself but also ensuring the freedom for all to act on that justice in meaningful ways, leading to flourishing.

Authors

Institutions

Publication Details

Journal
Ethik in der Medizin
Published
2025-09-01
DOI
https://doi.org/10.1007/s00481-025-00882-5
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Equity in newborn sequencing: a capability approach perspective

Kelly E. Ormond, Eirini Petrou
Ethik in der Medizin
Genomics and Rare Diseases
article

Equity in newborn sequencing: a capability approach perspective

Kelly E. Ormond, Eirini Petrou
article en

Abstract

Abstract Definition of the problem Newborn sequencing (NBSeq) offers the potential to detect hundreds of genetic conditions from infancy. On this basis, some consider NBSeq to be a revolutionizing equalizer, promising access to genomic testing for all newborns. However, the unique nature of equity in NBSeq has been oversimplified in the literature; the existing debate mainly highlights universal access as an automatic means of ensuring fair health outcomes. Arguments We apply the Capability Approach (CA) to argue that providing access alone is not sufficient to achieve equity. Instead, the emphasis should be placed on developing capabilities that enable people to use NBSeq effectively and achieve meaningful health outcomes. Using capabilities as a measure of justice and eventually developing our own list, we provide an overview of systemic barriers within the process, including the underrepresentation of genomic data and variations in health literacy. This model allows us to extrapolate how these factors can affect individuals—particularly those from underserved backgrounds—in their ability to translate the benefits and outcomes provided by NBSeq into improved well-being throughout their lifespan. Conclusion The CA provides a pluralistic perspective on equity in NBSeq by emphasizing an important distinction for justice in healthcare: the distinction between simply doing NBSeq and having the real freedom to choose to do NBSeq and then doing it. Equity in NBSeq requires refining justice by not only increasing access to the service itself but also ensuring the freedom for all to act on that justice in meaningful ways, leading to flourishing.

Ethik in der MedizinVol. 37(3)
ETH Zurich (CH), Institute of Medical Ethics (GB)
Eidgenössische Technische Hochschule Zürich
Openalex Percentile: Top 74%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.